Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

NCT06826339 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
340
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tiger Biosciences, LLC.

Collaborators